Both Eli Lilly $LLY (+1,04 %) and Novo Nordisk $NVO (+0,92 %) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (+1,04 %) is on track to become the first trillion dollar drug-maker...😯